Review
Medicine, General & Internal
Rani Khatib, Fatima R. N. Sabir, Caroline Omari, Chris Pepper, Muzahir Hassan Tayebjee
Summary: Many drug therapies can prolong the QT interval and increase the risk of Torsades de Pointes. Consideration of patient-related risk factors, the potential risk of QT prolongation with a drug, and co-prescribed medicines that may increase the risk are crucial when prescribing drugs associated with QT prolongation.
POSTGRADUATE MEDICAL JOURNAL
(2021)
Article
Public, Environmental & Occupational Health
Usha Yendrapalli, Hassoun Ali, Jacqueline L. Green, Jonathan Edwards
Summary: This retrospective study evaluated the safety and effects of hydroxychloroquine and azithromycin treatment in hospitalized COVID-19 patients. Out of 21 patients, only one developed prolonged QTc > 500 ms. No patient experienced serious arrhythmic events. Most patients showed improvement and were discharged home or to inpatient rehabilitation.
JOURNAL OF INFECTION AND PUBLIC HEALTH
(2021)
Article
Pharmacology & Pharmacy
Haixia Shao, Dawei Shi, Ying Dai
Summary: This study investigated the association between linezolid (LZD) and QT interval prolongation. The results showed a significant association between LZD and QT interval prolongation, especially in patients with tuberculosis.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
(2023)
Article
Pharmacology & Pharmacy
Akira Takahara, Satoshi Kawakami, Megumi Aimoto, Yoshinobu Nagasawa
Summary: This study found that the torsadogenic potential of ivabradine may become evident when its expected bradycardic action appears more excessively.
BIOLOGICAL & PHARMACEUTICAL BULLETIN
(2021)
Article
Physiology
Herman D. Himel, Michael Cupelli, Mohamed Boutjdir, Nabil El-Sherif
Summary: Through research in a guinea pig surrogate model of LQTS, it was found that NST TdP VT had higher E-d values compared to ST TdP VT, and early uncoupling of V-m/Ca-i wave fronts led to destabilization of wave propagation, potentially explaining sustained complex reentrant excitation patterns.
FRONTIERS IN PHYSIOLOGY
(2021)
Article
Pharmacology & Pharmacy
Satoshi Kawakami, Ryuichi Kambayashi, Kazuhiro Takada, Megumi Aimoto, Yoshinobu Nagasawa, Akira Takahara
Summary: This study analyzed the role of cardiac alpha(1)-adrenoreceptors in the torsadogenic action of I-Kr blocker nifekalant in isoflurane-anesthetized atrioventricular block rabbits. The results suggest that methoxamine activates cardiac alpha(1)-adrenoreceptors and sensitizes the rabbit heart to nifekalant-induced QT interval prolongation, leading to the onset of TdP.
JOURNAL OF PHARMACOLOGICAL SCIENCES
(2022)
Review
Cardiac & Cardiovascular Systems
Christian Ellermann, Julian Wolfes, Lars Eckardt, Gerrit Frommeyer
Summary: Many non-cardiovascular drugs can alter cardiac electrophysiology and potentially lead to life-threatening arrhythmias. In addition to measuring the QT interval, other markers are considered to assess the potential harm of drugs on cardiac electrophysiology. The rabbit heart, with similarities to the human heart in ion currents distribution and pharmacologic response, is particularly suitable for testing the electrophysiologic safety of drugs.
Article
Cardiac & Cardiovascular Systems
Raphael Rosso, Aviram Hochstadt, Dana Viskin, Ehud Chorin, Arie Lorin Schwartz, Oholi Tovia-Brodie, Avishag Laish-Farkash, Ofer Havakuk, Lior Gepstein, Shmuel Banai, Sami Viskin
Summary: Distinct types of polymorphic ventricular tachycardia respond differently to therapy, and this study aimed to define the electrocardiographic characteristics of different forms of polymorphic VT. The study group included patients with coronary artery disease and spontaneous polymorphic VT triggered by short-coupled extrasystoles, as well as patients with ventricular fibrillation during acute myocardial infarction and drug-induced TdP. Pseudo-TdP patients had a longer QT interval compared to those with normal QT and a shorter QT interval compared to true TdP patients, with the coupling interval of the ectopic beat playing a crucial role in differentiating these groups.
EUROPEAN HEART JOURNAL
(2021)
Article
Medicine, General & Internal
Sok-Sithikun Bun, Nathan Heme, Florian Asarisi, Fabien Squara, Didier Scarlatti, Pamela Moceri, Emile Ferrari
Summary: This study analyzed the clinical characteristics of patients with high-grade atrioventricular block (AVB) presenting with torsades de pointes (TdP), and found that the QTc(FR), JT, and Tpeak-to-end intervals were significantly prolonged in these patients.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Xia-yan Zhang, Cha-bin Wu, Cai-xia Wu, Li Lin, Yue-juan Zhou, Yan-yan Zhu, Wei-qiang Tian, Song-mei Luo
Summary: A 68-year-old female with EGFR mutant lung cancer developed TdP while being treated with osimertinib. The prolongation of QT interval was partly attributed to the Traditional Chinese Medicine, Litsea Cubeba. Discontinuation of osimertinib and Litsea Cubeba, along with magnesium and potassium supplementation, lidocaine infusion and pacemaker frequency adjustment, led to the termination of TdP. However, QT prolongation persisted at discharge due to emergency use of amiodarone.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Ying Liao, Shanshan Shi, Lihua Liao, Yukun Zhao, Rongwen Lin, Kaihong Chen
Summary: In this article, we report a female patient with acquired long QT syndrome, which is a rare complication of pheochromocytoma. The presence of pheochromocytoma should be considered in the case of malignant arrhythmias and electrocardiographic changes in patients, despite its rarity.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Joe-Elie Salem, Lee S. Nguyen, Javid J. Moslehi, Stephane Ederhy, Benedicte Lebrun-Vignes, Dan M. Roden, Christian Funck-Brentano, Paul Gougis
Summary: The study compared the risk of drug-induced long QT and ventricular arrhythmias for 663 anticancer drugs with other drugs, proposing a three-level sudden death risk stratification based on the findings. This list of potentially dangerous anticancer drugs may be helpful for physicians and regulatory authorities in reassessing cardiac monitoring requirements.
EUROPEAN HEART JOURNAL
(2021)
Article
Pharmacology & Pharmacy
Melissa Y. Y. Moey, Marie Wilkin, Estelle Gandjbakhch, Anne Bachelot, Baptiste Abbar, Bruno Pinna, Jean-Marc Simon, Christian Funck-Brentano, Joe-Elie Salem
Summary: The prevalence and incidence of cardiac pro-arrhythmic disorders are influenced by sex due to the effects of androgens on the QT interval. Androgens can shorten QT interval, providing protection against acquired long QT syndromes in men. However, androgens can also potentiate Brugada and early repolarization syndromes, which are more prevalent in men.
Article
Cardiac & Cardiovascular Systems
Dana Viskin, Amir Halkin, Jack Sherez, Ricki Megidish, Dana Fourey, Gad Keren, Yan Topilsky
Summary: In patients with high-grade atrioventricular block, clinical heart failure occurrence is associated with impaired left ventricular compliance and diastolic mitral regurgitation volume, rather than heart rate or left ventricular ejection fraction. Patients with poor left ventricular compliance and high-volume diastolic mitral regurgitation may exhibit maladjustment to slow heart rates, leading to low cardiac output and heart failure.
CANADIAN JOURNAL OF CARDIOLOGY
(2021)
Article
Clinical Neurology
Huicong Kang, Lili Lan, Yuchao Jia, Cun Li, Yongkang Fang, Suiqiang Zhu, Heidi Kirsch
Summary: Long QT syndrome (LQTS), especially LQTS type 2 (LQT2), can often be misdiagnosed as refractory epilepsy and treated incorrectly with anti-epileptic drugs (AEDs), increasing the risk of sudden cardiac death. Careful evaluation with electrocardiography and genetic testing is crucial for accurate diagnosis.